FIELD: medicine.
SUBSTANCE: invention refers to an experimental medicine, namely to oncology and may be used to inhibit migration of cancer cells. The method represents provision of contacting of tumor cell of nonlymphocytic character with an effective amount of an antibody against ubiquitin.
EFFECT: use of invention enables to hinder development of metastasis due to blocking motility and extravasation of cancer cells under the action of antibodies to ubiquitin.
8 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AXL SIGNALLING INHIBITION IN ANTIMETASTATIC THERAPY | 2011 |
|
RU2556822C2 |
| INHIBITION OF DISSEMINATION OF TUMOUR USING Bv8 OR G-CSF ANTAGONISTS | 2010 |
|
RU2567803C2 |
| PDGFRα ANTIBODIES FOR TREATING SECONDARY BONE TUMOUR | 2006 |
|
RU2502523C2 |
| COMBINED THERAPY PAC-1 | 2016 |
|
RU2720509C2 |
| ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF | 2011 |
|
RU2595403C2 |
| METHOD OF THE MELANOMA TUMOR NODES FORMATION IN THE BODY OF EXPERIMENTAL ANIMALS | 2022 |
|
RU2796892C1 |
| METHODS AND COMPOSITIONS FOR MODULATION AND DETECTION WISP ACTIVITY | 2006 |
|
RU2412201C2 |
| METHOD FOR DETECTING PROPERTIES OF HUMAN GLIOBLASTOMA MITOCHONDRIA TO INDUCE EXTRACRANIAL DIFFUSE TUMOR GROWTH IN THE ORGANS OF EXPERIMENTAL ANIMALS | 2023 |
|
RU2794641C1 |
| CD43 ANTIBODIES AND USE THEREOF FOR TREATING CANCER | 2016 |
|
RU2694903C1 |
| METHODS AND NUTRITIONAL FORMULATIONS FOR INCREASING EFFECTIVENESS AND REDUCING SIDE EFFECTS OF CANCER TREATMENT | 2010 |
|
RU2549954C2 |
